Abraham Scaria MSc, PhD

Dr. Abraham Scaria is Vice President, Head of Ophthalmology at Casebia Therapeutics. Dr. Scaria has more than 20 years of experience in gene therapy, ranging from discovery research to clinical trials. For much of his career, Scaria has specialized in viral vectors and ocular gene therapy, having served as Senior Scientific Director of Gene Therapy and Ophthalmology at Genzyme, and subsequently Sanofi Genzyme. He most recently served as Head of Gene Therapy Research at Sanofi. He earned his Ph.D. in biochemistry and molecular biology from Indiana University School of Medicine followed by postdoctoral research at St. Louis University School of Medicine and University of Washington in Seattle.